Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheid

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Virology|October 30, 1981
the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptideM H Heggeness, A Scheid, P W Choppin
Neurology|May 1, 1975
Proceedings: Paramyxoviruses, membranes, and persistent infectionsP W Choppin, A Scheid, W E Mountcastle
Infection and Immunity|April 1, 1978
Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activationS M Silver, A Scheid, P W Choppin
The Journal of Experimental Medicine|February 1, 1980
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infectionD C Merz, A Scheid, P W Choppin
Virology|February 1, 1981
Immunological studies of the functions of paramyxovirus glycoproteinsD C Merz, A Scheid, P W Choppin
Virology|January 1, 1987
Protease activation mutants of Sendai virus: sequence analysis of the mRNA of the fusion protein (F) gene and direct identification of the cleavage-activation siteM C Hsu, A Scheid, P W Choppin
Experimental Physiology|February 24, 2001
Genetically modified mouse models in studies on cutaneous wound healingA Scheid, M Meuli, M Gassmann, et al.
Journal of Virology|January 1, 1996
Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayerI Martin, H Schaal, A Scheid, et al.
Deutsche Medizinische Wochenschrift (1946)|October 10, 1986
[HTLV-III antibodies in hemodialysis patients and following kidney transplantation]B Grabensee, P Heering, P Heinzler, et al.
Virology|August 4, 2001
Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expressionJ Krummheuer, C Lenz, S Kammler, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Virology|October 30, 1981
the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptideM H Heggeness, A Scheid, P W Choppin
Neurology|May 1, 1975
Proceedings: Paramyxoviruses, membranes, and persistent infectionsP W Choppin, A Scheid, W E Mountcastle
Infection and Immunity|April 1, 1978
Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activationS M Silver, A Scheid, P W Choppin
The Journal of Experimental Medicine|February 1, 1980
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infectionD C Merz, A Scheid, P W Choppin
Virology|February 1, 1981
Immunological studies of the functions of paramyxovirus glycoproteinsD C Merz, A Scheid, P W Choppin
Virology|January 1, 1987
Protease activation mutants of Sendai virus: sequence analysis of the mRNA of the fusion protein (F) gene and direct identification of the cleavage-activation siteM C Hsu, A Scheid, P W Choppin
Experimental Physiology|February 24, 2001
Genetically modified mouse models in studies on cutaneous wound healingA Scheid, M Meuli, M Gassmann, et al.
Journal of Virology|January 1, 1996
Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayerI Martin, H Schaal, A Scheid, et al.
Deutsche Medizinische Wochenschrift (1946)|October 10, 1986
[HTLV-III antibodies in hemodialysis patients and following kidney transplantation]B Grabensee, P Heering, P Heinzler, et al.
Virology|August 4, 2001
Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expressionJ Krummheuer, C Lenz, S Kammler, et al.
Pageof 6